The company provides services such as nanobody (single domain antibody) screening platform, mouse monoclonal antibody platform, CAR-T development and verification, yeast display library platform, etc. The team is engaged in recombinant viruses (adenovirus, lentivirus), antibody humanization, immune Cell drugs and other aspects have strong R&D capabilities and super project delivery capabilities.